Sichuan Huiyu Pharmaceutical Co., Ltd

This study is testing whether a generic version of the chemotherapy drug paclitaxel albumin-bound works the same as the brand-name version in people with breast cancer. The trial involves 24 participants who will receive both versions at different times to compare how the drug be…

This early-phase trial is testing a new drug called HY0001a in 261 people with advanced solid tumors who have no other treatment options. The study aims to find a safe dose and see if the drug can shrink tumors. It is currently recruiting participants.

This study tests a new drug called HY07121 in 258 adults with advanced solid tumors that have not responded to standard treatments. The drug is given by IV infusion. The main goals are to check safety, find the right dose, and see if it can shrink tumors. This is an early-stage t…

This study tests an experimental drug, HYP-2090PTSA, in people with advanced solid tumors that have a specific genetic change called KRAS mutation. The trial has two parts: first, finding the safest dose, and then testing how well that dose works in certain cancers. About 257 adu…

This study tests a new drug called HYP-6589, alone or with other cancer drugs, in people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and shrinks tumors. About 115 adults aged 18–80 with certain genetic marker…

This study tests a new drug called HY05350 in people with advanced solid tumors that have a protein called MSLN on their surface. The trial has two parts: first, finding a safe dose, and second, seeing if the drug shrinks tumors. About 262 participants who have exhausted standard…

This early-stage trial tests a new drug called HY-2003, a fat-dissolving injection for people with moderate to severe double chin. About 30 adults will receive either HY-2003, an existing treatment (BELKYRA), or a placebo. The main goal is to check safety, but researchers will al…

This Phase 1 trial is comparing a generic version of the iron injection ferric carboxymaltose to the brand-name drug Injectafer in 70 healthy adults. The goal is to see if the generic works the same way in the body and is safe. Participants receive a single dose of either drug an…